Medica RCP |Neupogen 30MU Vials | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Neupogen 30MU Vials

Contraindicated
Reproductive toxicity in animals

Contraindicated

Neupogen 30MU Vials :
Type	Medicine Non Marketed
Originator	Nivestim 30MU Vials°
Agent	Mersaco
Distributor	Mersaco
Laboratory	Amgen
Responsible Party	Amgen Europe BV
Origin	The Netherlands
Manufacturer	Amgen Europe BV
Origin	The Netherlands
ATC	L03AA02

Neupogen 30MU Vials :

Injectable

Intravenous

Subcutaneous

Neupogen 30MU Vials :

L Antineoplastic and immunomodulating agents

L03 Immunostimulants

L03A Immunostimulants

L03AA Colony stimulating factors

L03AA02 Filgrastim

Neupogen 30MU Vials :

Filgrastim : 30MU

Neupogen 30MU Vials :

Adults : Mobilisation of blood progenitor cells 10 µg/kg/day

Adults : Severe congenital neutropenia 12 µg/kg/day

Adults : Severe idiopathic neutropenia 5 µg/kg/day

Neupogen 30MU Vials :

Polysorbate 80 (E433) Emulsifying Agents

Sodium acetate

Sorbitol (E420)*

Water for injections

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Neupogen 30MU Vials :

Revision Date : 06/02/2015

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Acute febrile neutrophilic dermatosis (Sweet's syndrome)	Uncommon
Acute respiratory distress syndrome	Uncommon
Alopecia	Very Common
Anaemia	Very Common
Anaphylaxis	Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema)	Not known
Anorexia	Very Common
Arthralgia (Pain joint) (Joint ache)	Very Common
AST increased	Uncommon
Asthenia	Very Common
Back pain	Very Common
Blood alkaline phosphatase increased	Very Common
Blood glucose decreased	Very Common
Blood lactate dehydrogenase increased	Very Common
Blood uric acid increased	Very Common
Bone density decreased	Common
Bone pain	Very Common
Capillary leak syndrome	Uncommon
Chest pain	Common
Constipation	Very Common
Cough	Very Common
Cutaneous vasculitis	Common
Diarrhoea (Diarrhea)	Very Common
Drug hypersensitivity	Common
Dyspnoea (dyspnea)	Very Common
Dysuria (Micturition painful)	Common
Epistaxis (Nasal bleeding)	Very Common
Fatigue	Very Common
Fluid volume Disturbances	Uncommon
Gamma-GT increased	Very Common
Graft versus host disease	Uncommon
Haematuria (Hematuria)	Common
Haemoptysis	Common
Headache	Very Common
Hepatomegaly	Very Common
Hypersensitivity	Not known
Hyperuricaemia	Very Common
Hypotension	Common
Hypoxia	Uncommon
Injection site reaction	Common
Interstitial pneumonitis	Uncommon
Leukaemia	Not known
Leukocytosis	Very Common
Lung infiltration (pulmonary infiltration)	Uncommon
Mucosal inflammation	Very Common
Musculoskeletal chest pain	Very Common
Musculoskeletal pain	Very Common
Myalgia	Very Common
Myelodysplastic syndrome	Not known
Nausea	Very Common
Neck pain	Very Common
Osteoporosis	Common
Pain	Uncommon
Pain in extremity (Pain in limb)	Very Common
Pharyngolaryngeal pain	Very Common
Proteinuria	Uncommon
Pseudogout	Uncommon
Pulmonary haemorrhage	Uncommon
Pulmonary oedema	Uncommon
Respiratory failure	Uncommon
Rheumatoid arthritis aggravated	Uncommon
Sickle cell crisis	Uncommon
Skin rash	Very Common
Splenic rupture	Common
Splenomegaly (Spleen enlarged)	Very Common
Thrombocytopenia (Thrombopenia)	Very Common
Urine abnormality	Uncommon
Urticaria	Not known
Venoocclusive disease	Uncommon
Vomiting	Very Common

Neupogen 30MU Vials :

Belgium

Czech Republic

Denmark

Finland

France

Germany

Ireland

KSA

Kuweit

New Zealand

Portugal

Qatar

Spain

Sweden

Switzerland

The Netherlands

UAE

Medicine Authorised

Mozobil

Mersaco

Genzyme Therapeutics

Medicine Authorised

Neograstim 30MU Syringe

Benta Trading Co

Benta Laboratories

Medicine Authorised

Neupogen 30MU Syringe

Mersaco

Amgen

Medicine Authorised

Neutromax 30MU Vial

Droguerie Phenicia

BioSidus

Medicine Authorised

Nivestim 30MU Syringes

Food & Drug Corporation

Pfizer

Medicine Authorised

Revixil

Droguerie Phenicia

Gador

Medicine Authorised

Zarzio 30MU Syringes

Khalil Fattal & Fils

Sandoz

Medicine Authorised

Zarzio 30MU Syringes²

Khalil Fattal & Fils

Sandoz

NB : Products With Same Indication

Coming Very Soon

Different Units By MoH Code

Revision Date : 01/03/2019

Revision Date : 01/09/2007

Neupogen 30MU Vials MoH 7964 :

Form Solution for injection

Packaging Vial (Type I Glass)

Package Size 5x1ml

Strength 30MU

NSSF ✘

Quarantine ✘

Reg. Number 5015/1

Submission date 01/01/2014

Registration Year 2015

Archived Date 02/03/2023

Price Comparison

You have to register to view this info

Note

You have to register to view this info

Stat by year

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Solution for injection
Packaging	Vial (Type I Glass)
Package Size	5x1ml
Strength	30MU
NSSF	✘
Quarantine	✘
Reg. Number	5015/1
Submission date	01/01/2014
Registration Year	2015
Archived Date	02/03/2023